Hyperpolarisation-activated cyclic nucleotide channel 4 (HCN4) involvement in Tourette's syndrome autoimmunity

Journal of Neuroimmunology

Volumn 250, Issue 1-2, 2012, Pages 18-26

  Yeh, Chin Bin ^a,b   Shui, Hao Ai ^b   Chu, Tzu Hui ^a,b   Chen, Yu An ^b   Tsung, Hui Chu ^b   Shyu, Jia Fwu ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Attention deficit hyperactivity disorder; Autoantibodies; Hyperpolarisation activated cyclic nucleotide channel 4; Neuropsychiatric disorder; Tourette's syndrome

Indexed keywords

BRAIN PROTEIN; HYPERPOLARISATION ACTIVATED CYCLIC NUCLEOTIDE CHANNEL 4; HYPERPOLARISATION ACTIVATED CYCLIC NUCLEOTIDE CHANNEL 4 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CELL ASSAY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SCHOOL CHILD; STEREOTYPY; WESTERN BLOTTING;

ADOLESCENT; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; BLOTTING, WESTERN; CHILD; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MALE; MUSCLE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TOURETTE SYNDROME;

EID: 84864861284     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.05.009     Document Type: Article

References (49)

1. Arnsten A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 2009, 10:410-422.
2. Barth A.M., Vizi E.S., Zelles T., Lendvai B. Alpha2-adrenergic receptors modify dendritic spike generation via HCN channels in the prefrontal cortex. J. Neurophysiol. 2008, 99:394-401.
3. Baym C.L., Corbett B.A., Wright S.B., Bunge S.A. Neural correlates of tic severity and cognitive control in children with Tourette syndrome. Brain 2008, 131:165-179.
4. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
5. Boyes J., Bolam J.P., Shigemoto R., Stanford I.M. Functional presynaptic HCN channels in the rat globus pallidus. Eur. J. Neurosci. 2007, 25:2081-2092.
6. Chan C.S., Shigemoto R., Mercer J.N., Surmeier D.J. HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons. J. Neurosci. 2004, 24:9921-9932.
7. Chappell P.B., Riddle M.A., Scahill L., Lynch K.A., Schultz R., Arnsten A., Leckman J.F., Cohen D.J. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J. Am. Acad. Child Adolesc. Psychiatry 1995, 34:1140-1146.
8. Church A.J., Dale R.C., Lees A.J., Giovannoni G., Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J. Neurol. Neurosurg. Psychiatry 2003, 74:602-607.
9. Cohen D.J., Detlor J., Young J.G., Shaywitz B.A. Clonidine ameliorates Gilles de la Tourette syndrome. Arch. Gen. Psychiatry 1980, 37:1350-1357.
10. Dale R.C., Candler P.M., Church A.J., Wait R., Pocock J.M., Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J. Neuroimmunol. 2006, 172:187-197.
11. Day M., Carr D.B., Ulrich S., Ilijic E., Tkatch T., Surmeier D.J. Dendritic excitability of mouse frontal cortex pyramidal neurons is shaped by the interaction among HCN, Kir2, and Kleak channels. J. Neurosci. 2005, 25:8776-8787.
12. Eapen V., Fox-Hiley P., Banerjee S., Robertson M. Clinical features and associated psychopathology in a Tourette syndrome cohort. Acta Neurol. Scand. 2004, 109:255-260.
13. Fontan P.A., Pancholi V., Nociari M.M., Fischetti V.A. Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. J. Infect. Dis. 2000, 182:1712-1721.
14. Franz O., Liss B., Neu A., Roeper J. Single-cell mRNA expression of HCN1 correlates with a fast gating phenotype of hyperpolarization-activated cyclic nucleotide-gated ion channels (Ih) in central neurons. Eur. J. Neurosci. 2000, 12:2685-2693.
15. Gause C., Morris C., Vernekar S., Pardo-Villamizar C., Grados M.A., Singer H.S. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J. Neuroimmunol. 2009, 214:118-124.
16. Hallett J.J., Harling-Berg C.J., Knopf P.M., Stopa E.G., Kiessling L.S. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J. Neuroimmunol. 2000, 111:195-202.
17. Hallworth N.E., Wilson C.J., Bevan M.D. Apamin-sensitive small conductance calcium-activated potassium channels, through their selective coupling to voltage-gated calcium channels, are critical determinants of the precision, pace, and pattern of action potential generation in rat subthalamic nucleus neurons in vitro. J. Neurosci. 2003, 23:7525-7542.
18. Kansy J.W., Katsovich L., McIver K.S., Pick J., Zabriskie J.B., Lombroso P.J., Leckman J.F., Bibb J.A. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J. Neuroimmunol. 2006, 181:165-176.
19. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies: tics and obsessive-compulsive symptoms. J. Dev. Behav. Pediatr. 1994, 15:421-425.
20. Kirvan C.A., Swedo S.E., Kurahara D., Cunningham M.W. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 2006, 39:21-29.
21. Kretschmannova K., Gonzalez-Iglesias A.E., Tomić M., Stojilkovic S.S. Dependence of hyperpolarisation-activated cyclic nucleotide-gated channel activity on basal cyclic adenosine monophosphate production in spontaneously firing GH3 cells. J. Neuroendocrinol. 2006, 18:484-493.
22. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., Cohen D.J. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry 1989, 28:566-573.
23. Leckman J.F., Hardin M.T., Riddle M.A., Stevenson J., Ort S.I., Cohen D.J. Clonidine treatment of Gilles de la Tourette's syndrome. Arch. Gen. Psychiatry 1991, 48:324-328.
24. Leckman J.F., Katsovich L., Kawikova I., Lin H., Zhang H., Krönig H., Morshed S., Parveen S., Grantz H., Lombroso P.J., King R.A. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol. Psychiatry 2005, 57:667-673.
25. Liu X., Wang Y., Li D., Ju X. Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Behav. Brain Res. 2008, 186:84-90.
26. Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 1998, 393:587-591.
27. Martino D., Church A.J., Defazio G., Dale R.C., Quinn N.P., Robertson M.M., Livrea P., Orth M., Giovannoni G. Soluble adhesion molecules in Gilles de la Tourette's syndrome. J. Neurol. Sci. 2005, 234:79-85.
28. Martino D., Dale R.C., Gilbert D.L., Giovannoni G., Leckman J.F. Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov. Disord. 2009, 24:1267-1279.
29. Matsuo K., Xiang Y., Nakamura H., Masuko K., Yudoh K., Noyori K., Nishioka K., Saito T., Kato T. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res. Ther. 2006, 8:R175.
30. Mink J.W. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatr. Neurol. 2001, 25:190-198.
31. Moosmang S., Stieber J., Zong X., Biel M., Hofmann F., Ludwig A. Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur. J. Biochem. 2001, 268:1646-1652.
32. Morer A., Lázaro L., Sabater L., Massana J., Castro J., Graus F. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. J. Psychiatr. Res. 2008, 42:64-68.
33. Morshed S.A., Parveen S., Leckman J.F., Mercadante M.T., Bittencourt Kiss M.H., Miguel E.C., Arman A., Yazgan Y., Fujii T., Paul S., Peterson B.S., Zhang H., King R.A., Scahill L., Lombroso P.J. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol. Psychiatry 2001, 50:566-577.
34. Rizzo R., Gulisano M., Pavone P., Fogliani F., Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J. Child Neurol. 2006, 21:747-753.
35. Robinson R.B., Siegelbaum S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu. Rev. Physiol. 2003, 65:453-480.
36. Santoro B., Tibbs G.R. The HCN gene family: molecular basis of the hyperpolarization-activated pacemaker channels. Ann. N. Y. Acad. Sci. 1999, 868:741-764.
37. Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R., Siegelbaum S.A., Tibbs G.R. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 1998, 93:717-729.
38. Scahill L., Chappell P.B., Kim Y.S., Schultz R.T., Katsovich L., Shepherd E., Arnsten A.F., Cohen D.J., Leckman J.F. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am. J. Psychiatry 2001, 158:1067-1074.
39. Seifert R., Scholten A., Gauss R., Mincheva A., Lichter P., Kaupp U.B. Molecular characterization of a slowly gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis. Proc. Natl. Acad. Sci. U. S. A. 1996, 96:9391-9396.
40. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., Kiessling L.S. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998, 50:1618-1624.
41. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., Kiessling L.S. Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome. Biol. Psychiatry 1999, 46:775-780.
42. Singer H.S., Hong J.J., Yoon D.Y., Williams P.N. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005, 65:1701-1707.
43. Smidt M.P., Asbreuk C.H., Cox J.J., Chen H., Johnson R.L., Burbach J.P. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 2000, 3:337-341.
44. Taylor J.R., Morshed S.A., Parveen S., Mercadante M.T., Scahill L., Peterson B.S., King R.A., Leckman J.F., Lombroso P.J. An animal model of Tourette's syndrome. Am. J. Psychiatry 2002, 159:657-660.
45. The Tourette Syndrome Classification Study Group Definitions and classification of tic disorders. Arch. Neurol. 1993, 50:1013-1016.
46. Wang M., Ramos B.P., Paspalas C.D., Shu Y., Simen A., Duque A., Vijayraghavan S., Brennan A., Dudley A., Nou E., Mazer J.A., McCormick D.A., Arnsten A.F. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 2007, 129:397-410.
47. Wendlandt J.T., Grus F.H., Hansen B.H., Singer H.S. Striatal antibodies in children with Tourette's syndrome: multivariate discriminant analysis of IgG repertoires. J. Neuroimmunol. 2001, 119:106-113.
48. Yeh C.B., Wu C.H., Tsung H.C., Chen C.W., Shyu J.F., Leckman J.F. Antineural antibody in patients with Tourette's syndrome and their family members. J. Biomed. Sci. 2006, 13:101-112.
49. Zhang Y., Gao D., Bolivar V.J., Lawrence D.A. Induction of autoimmunity to brain antigens by developmental mercury exposure. Toxicol. Sci. 2011, 119:270-280.